Tyler Carllee, MD
Orthopaedic Surgery · Fayetteville, ARNPI 1003228891
Payments from drug & device makers
What this record shows
This record is dominated by grants: $45,000 of the $59,710 with a category attached, or 75.4%. 8 manufacturers reported payments, led by Lima USA, Inc. at 41.9% of the total. Reporting peaked in 2020 at $32,095 and has fallen 99.6% since, to $140 in 2023. Among orthopaedic surgery clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $1388.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lima USA, Inc.$25K
- Arthrex$20K
- Smith+Nephew$10K
- Peerless Surgical Inc.$2K
- Midsouth Orthopedics Inc.$2K
- Stryker$175
- plus $283 from 2 others
What the payments were for
- Grants$45,00075%
- Travel & lodging$6881%
- Food & beverage$9882%
- Education$13,03422%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lima USA, Inc. | 3 | $25,015 |
| Arthrex | 15 | $20,419 |
| Smith+Nephew | 6 | $10,185 |
| Peerless Surgical Inc. | 5 | $2,074 |
| Midsouth Orthopedics Inc. | 6 | $1,558 |
| Stryker(2 entities) | 4 | $175 |
| DJO, LLC | 1 | $149 |
| Johnson & Johnson | 3 | $133 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,710 in reported general payments places this provider in the 90th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $2,019 |
| Methylprednisolone | 17 | $140 |
| Meloxicam | 46 | $101 |
| Ondansetron OdtOndansetron | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fayetteville
- Wesley CoxFayetteville$309K
- William GrammerFayetteville$9K
- Devin St ClairFayetteville$8K
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- William HefleyNorth Little Rock$306K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason BrandtJonesboro$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.